[Prescribe and advise freely].
Physicians know how totally unrealistic it is to expect drug companies to furnish reliable comparative information to assist therapeutic decision-making. All hope in this regard must be founded on personal effort to sort through available data and on independent reasoning. This evaluation process must be based on international nonproprietary names (INN) far removed from the advertising campaigns devised by companies.